A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC

NCT05410730 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

High-risk NMIBC

Interventions

DRUG: SHR-1501

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.